| Literature DB >> 35799916 |
Mohammad Qutob1, Mahmoud A Hussein2, Khalid A Alamry2, Mohd Rafatullah1.
Abstract
Water scarcity and the accumulation of recalcitrance compounds into the environment are the main reasons behind the attraction of researchers to use advanced oxidation processes (AOPs). Many AOP systems have been used to treat acetaminophen (ACT) from an aqueous medium, which leads to generating different kinetics, mechanisms, and by-products. In this work, state-of-the-art studies on ACT by-products and their biotoxicity, as well as proposed degradation pathways, have been collected, organized, and summarized. In addition, the Fukui function was used for predicting the most reactive sites in the ACT molecule. The most frequently detected by-products in this review were hydroquinone, 1,4-benzoquinone, 4-aminophenol, acetamide, oxalic acid, formic acid, acetic acid, 1,2,4-trihydroxy benzene, and maleic acid. Both the experimental and prediction tests revealed that N-(3,4-dihydroxy phenyl) acetamide was mutagenic. Meanwhile, N-(2,4-dihydroxy phenyl) acetamide and malonic acid were only found to be mutagenic in the prediction test. The findings of the LC50 (96 h) test revealed that benzaldehyde is the most toxic ACT by-products and hydroquinone, N-(3,4-dihydroxyphenyl)formamide, 4-methylbenzene-1,2-diol, benzoquinone, 4-aminophenol, benzoic acid, 1,2,4-trihydroxybenzene, 4-nitrophenol, and 4-aminobenzene-1,2-diol considered harmful. The release of them into the environment without treatment may threaten the ecosystem. The degradation pathway based on the computational method was matched with the majority of ACT proposed pathways and with the most frequent ACT by-products. This study may contribute to enhance the degradation of ACT by AOP systems. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35799916 PMCID: PMC9214717 DOI: 10.1039/d2ra02469a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
List of main proposed by-products to build ACT degradation pathways
| Product number | Chemical formula and molecular weight | Chemical structure | Product number | Chemical formula and molecular weight | Chemical structure |
|---|---|---|---|---|---|
| P1 | C6H5Cl2NO, |
| P31 | C2H2O4, |
|
| P2 | C8H11NO3, |
| P32 | C4H8O2, |
|
| P3 | C8H9NO3, |
| P33 | C4H4O4, |
|
| P4 | C6H6O2, |
| P34 | C4H6O6, |
|
| P5 | C2H5NO, |
| P35 | C4H6O5, |
|
| P6 | C6H7NO, |
| P36 | C2H4O2, |
|
| P7 | C8H9NO3, |
| P37 | NO3−, |
|
| P8 | C6H4O2( |
| P38 | CH2O2, |
|
| P9 | C8H11NO4, |
| P39 | C2H7N, |
|
| P10 | C6H6ClNO, |
| P40 | C8H9NO2, |
|
| P11 | C6H6O3, |
| P41 | C7H8O2, |
|
| P12 | C6H5NO3, |
| P42 | C6H4N2O5, |
|
| P13 | C16H16N2O4, |
| P43 | C5H11NO, |
|
| P14 | C5H7NO3, |
| P44 | C7H5ClO2, |
|
| P15 | C8H7NO2, |
| P45 | C6H6O2, |
|
| P16 | C6H6O, |
| P46 | C7H8O2, |
|
| P17 | C8H9NO2, |
| P47 | C4H9NO2, |
|
| P18 | C7H7NO3, |
| P48 | CH3NO2, |
|
| P19 | C2H3NO3, |
| P49 | C8H9NO3, |
|
| P20 | C8H8O2, |
| P50 | C4H11N, |
|
| P21 | C7H6O2, |
| P51 | C7H9NO, |
|
| P22 | C7H8O2, |
| P52 | C6H8NO, |
|
| P23 | NH4+, |
| P53 | C4H6O4, |
|
| P24 | C8H7Cl2NO2, |
| P54 | C8H9NO5, |
|
| P25 | C4H4O4, |
| P55 | C6H6O4, |
|
| P26 | C2H4O3, |
| P56 | C6H7NO2, |
|
| P27 | C7H7NO3, |
| P57 | C7H16O, |
|
| P28 | C3H4O4, |
| P58 | C6H12O, |
|
| P29 | C7H6O, |
| P59 | C3H6O3, |
|
| P30 | C6H5ClO2, |
|
Proposed oxidation pathways of ACT for more than 40 studies for different AOP systems
| Systems | Proposed pathways | Active radicals | References |
|---|---|---|---|
| O3/Fe2+ + Cu2+/UV | ACT → P4 → P8 → carboxylic acids → H2O + CO2 | ˙OH |
|
| P5 → P36, P38, or P23 | |||
| Fe2+/PS | (1) ACT → P6 → P4 → carboxylic acids → H2O + CO2 | SO4˙− and ˙OH |
|
| (2) ACT → P7 → P22 + P5 | |||
| P22 → carboxylic acids → H2O + CO2 | |||
| P7 → P21 + P5 | |||
| P21 → carboxylic acids → H2O + CO2 | |||
| P5 → P36, P38, or P23 | |||
| MgO/O3 | (1) ACT → P7 → P5 + P11 | ˙OH |
|
| P11 → P25 → P28 → P38 | |||
| P5 → P36, P38, or P23 | |||
| (2) ACT → P2 → P5 + P4 | |||
| P4 → P11 → P25 → P28 → P38 | |||
| P5 → P36, P38, or P23 | |||
| Photocatalytic degradation | (1) ACT → P2 → P5 + P4 | ˙OH |
|
| P4 → carboxylic acid → H2O + CO2 | |||
| (2) ACT → P49 → P4 → P5 → carboxylic acid → H2O + CO2 | |||
| Iron–copper/persulfate/PS | (1) ACT → P6 → P4 + P5 | SO4˙− and ˙OH |
|
| P4 → carboxylic acid → H2O + CO2 | |||
| (2) ACT → P7 → P5 + P11 | |||
| P11 → carboxylic acid → H2O + CO2 | |||
| TiO2/Fe2O3 core–shell nanostructure | (1) ACT → P3 → P11 → carboxylic acid → H2O + CO2 | ˙OH |
|
| (2) ACT → P4 → P11 → carboxylic acid → H2O + CO2 | |||
| (3) ACT → P7 → P11 → carboxylic acid → H2O + CO2 | |||
| Electro-Fenton and photoelectro-Fenton | ACT → P2 → P4 + P5 | ˙OH |
|
| P4 → P29 → P21 → carboxylic acid → H2O + CO2 | |||
| P5 → P39 → P23 → P37 | |||
| Catalytic wet peroxide oxidation (CWPO) | (1) ACT → P8 → P21 or P29 → P28, P36, P38, or P3 → H2O + CO2 | ˙OH |
|
| Solar light/Ag-g-C3N4/O3 | ACT → P7 → P54 → P55 → carboxylic acids → H2O + CO2 | h+ and ˙OH |
|
| La-doped | (1) ACT → P7 → P40 → P21 → H2O + CO2 | ˙OH |
|
| ZnO photocatalyst | (2) ACT → P9 → P8 + P5 | ||
| P8 → P4 → P19 → H2O + CO2 | |||
| P5 → P23 | |||
| Ag/AGCl@ZIF8/visible light | (1) ACT → P8 → carboxylic acid → H2O + CO2 | O2˙− |
|
| (2) ACT → P16 + P5 | |||
| P16 → carboxylic acid → H2O + CO2 | |||
| Peracetic acid/UVC-LED/Fe( | (1) ACT → P4 + P5 | ˙OH |
|
| (2) ACT → P56 → P4 → carboxylic acid → H2O + CO2 | |||
| (3) ACT → P12 or P4 → carboxylic acid → H2O + CO2 | |||
| (4) ACT → P7 → P56 → carboxylic acid → H2O + CO2 | |||
| ZVAl/H+/air system | ACT → P2 → P4 + P5 | ˙OH |
|
| P4 → carboxylic acids → H2O + CO2 | |||
| P5 → P36, P38, or P23 | |||
| CS–Fe/PS | (1) ACT → P16 + P5 | ˙OH and SO4˙− |
|
| P16 → P4 → P8 → carboxylic acid → H2O + CO2 | |||
| P5 → P39 → P23 | |||
| (2) ACT → P6 + P36 | |||
| P39 → P43 + P39 | |||
| P43 → carboxylic acid → H2O + CO2 | |||
| Cobalt-impregnated biochar/PMS | (1) ACT → P7 → P56 → P6 or P11 | ˙OH and SO4˙− |
|
| (2) ACT → P56 → P6 or P11 | |||
| (3) ACT → P6 → P4 → carboxylic acid → H2O + CO2 | |||
| P11 → P4 → carboxylic acid → H2O + CO2 | |||
| P6 → P4 → carboxylic acid → H2O + CO2 | |||
| Heat/peroxymonosulfate system | ACT → P6 → P56 or P12 | 1O2 and ˙OH |
|
| P12 → P25 or P28 → P36, P38, or P31 → CO2 + H2O | |||
| P56 → P31 → CO2 + H2O | |||
| Ferrous ion/copper oxide O2 | ACT → P2 → P4 → + P5 | ˙OH |
|
| P4 → P3 → P38 or P36 → H2O + CO2 | |||
| Fenton process by plasma gliding arc discharge | (1) ACT → P4 → P8 → carboxylic acid → H2O + CO2 | ˙OH |
|
| (2) ACT → P42 → P8 → carboxylic acid → H2O + CO2 | |||
| SnO2/O3 | (1) ACT → P7 → carboxylic acid → H2O + CO2 | ˙OH |
|
| (2) ACT → P4 + P5 | |||
| P4 → carboxylic acid → H2O + CO2 | |||
| P5 → P36 → P23 | |||
| OVPTCN/visible light | (1) ACT → P4 → P8 or P41 → P35 → H2O + CO2 | ˙OH |
|
| UV/H2O2 | ACT → P11, P7, P8, or P4 → carboxylic acid → H2O + CO2 | ˙OH and halide radicals |
|
| UV-LED/NH2Cl and PS | (1) ACT → P4 or P6 → P8 or P11 → carboxylic acid → H2O + CO2 | ˙OH, Cl˙ and SO4˙− |
|
| (2) ACT → P7 → P21 → P44 → carboxylic acid → H2O + CO2 | |||
| Photo Fenton-like oxidation process | (1) ACT → P13 | O2˙− |
|
| (2) ACT → P7 → P31 or P28 → P36 or P38 → H2O + CO2 | |||
| Photocatalytic degradation | (1) ACT → P13 | O2˙− and ˙OH |
|
| (2) ACT → P50, P28, or P33 → P36 or P38 → H2O + CO2 | |||
| Photocatalytic degradation | ACT → P4 + P5 | h+ and O2˙− |
|
| P4 → P11 → P38 or P25 → CO2 + H2O | |||
| P5 → P37 + CO2 + H2O | |||
| Photocatalytic degradation | ACT → P51 → P6 → P52 → P8 → P38 → P36 → CO2 + H2O | O2˙−, 1O2 and ˙OH |
|
| Photocatalytic | ACT → P6 → P16 → P4 → CO2 + H2O | ˙OH |
|
| Electro-Fenton process | (1) ACT → P4 + P5 | ˙OH |
|
| P4 → P8 or P11 → carboxylic acid → H2O + CO2 | |||
| (2) ACT → P3 → P8 → carboxylic acid → H2O + CO2 | |||
| Electrochemical degradation | (1) ACT → P6 → P4 | ˙OH |
|
| (2) ACT → P4+P5 | |||
| P4 → P8 → carboxylic acid → H2O + CO2 | |||
| P5 → P36, P38, or P23 | |||
| Electro-Fenton | (1) ACT → P8 → P21 or P29 → carboxylic acid → H2O + CO2 | ˙OH |
|
| (2) ACT → P7 → P21 or P29 → carboxylic acid → H2O + CO2 | |||
| Electrocatalytic degradation | (1) ACT → P7 or P3 → P5 + P21 | ˙OH |
|
| P21 → carboxylic acid → H2O + CO2 | |||
| (2) ACT → P4 + P5 | |||
| P4 → P11 or P8 → carboxylic acid → H2O + CO2 | |||
| P5 → P23 → P37 + CO2 + H2O | |||
| Electro-catalytic activation | ACT → P6 → P4 → P8 → P31 → CO2 + H2O | ˙OH |
|
| Heterogeneous electro-Fenton process | ACT → P5 → P16 | ˙OH |
|
| P16 → P57 or P58 → carboxylic acid → H2O + CO2 | |||
| Photo-Fenton | ACT → P4 + P5 | ˙OH |
|
| P4 → P8 → carboxylic acid → H2O + CO2 | |||
| P5 → P19 → P23 → CO2 | |||
| High active amorphous Co(OH)2/PMS | (1) ACT → P13 | ˙OH and SO4˙− |
|
| (2) ACT → P6 → P4 + P5 | |||
| P4 → P8 → P28 → CO2 + H2O | |||
| P5 → P36 or P38 | |||
| (3) ACT → P7 → P56 or P54 | |||
| P56 → P11 → P53 → CO2 + H2O | |||
| P54 → P55 → P53 → CO2 + H2O | |||
| BaTiO3/TiO2 composite-assisted photocatalytic | ACT → P2 → P4 → P8 → carboxylic acid → H2O + CO2 | ˙OH |
|
| Fuel cell-Fenton system | ACT → P6 + P36 | ˙OH |
|
| P6 → P12 → P25 → P35 or P28 | |||
| Electrochemical oxidation | ACT → P3 + P36 | ˙OH and SO4˙− |
|
| P6 → P4 or P12 → P8 → carboxylic acid → H2O + CO2 | |||
| Photo-electrooxidation | ACT → P4 + P5 | ˙OH |
|
| P4 → P8 → carboxylic acid → H2O + CO2 | |||
| Biotemplated copper oxide catalysts over graphene oxide for ACT removal | ACT → P4 → P8 → carboxylic acid → H2O + CO2 | ˙OH |
|
| Gas phase dielectric barrier discharge plasma combined with the titanium dioxide-reduced graphene oxide | ACT → P4 → P46 → carboxylic acid → H2O + CO2 | ˙OH |
|
| Photocatalytic degradation of acetaminophen | (1) ACT → P13 | ˙OH |
|
| (2) ACT → P4 → P8 → carboxylic acid → H2O + CO2 | |||
| (3) ACT → P7 → P11 → carboxylic acid → H2O + CO2 | |||
| (4) ACT → P3 → P11 → carboxylic acid → H2O + CO2 | |||
| Degradation of acetaminophen by ferrate ( | ACT → P16 or P52 → P25 → P38 → P31 → H2O + CO2 | Direct oxidation |
|
| Photocatalytic degradation of paracetamol | (1) ACT → P2 → P4 + P5 | ˙OH |
|
| P4 → P8 → carboxylic acid → H2O + CO2 | |||
| (2) ACT → P5 + P6 → P8 → carboxylic acid → H2O + CO2 |
Fig. 1(A) Represent ACT molecule and its f−, f+, and f° values. (B) Hydroquinone, and (C) 1,4-benzoquinone.
Fig. 2Illustrated the proposed degradation pathway based on computational method.
Number of detections of the most frequent by-products for different AOP systems
| Carboxylic acids compounds and small by-products | Number of detections | Remark | Quinone derivatives and aromatic by-products | Number of detections | Remark | References |
|---|---|---|---|---|---|---|
| Acetamide | 15 | Acetamide one of the most frequent by products in all AOP systems | Hydroquinone | 43 | Is the most frequent by products in all AOP systems |
|
| Oxalic acid | 14 | Detected in all AOP systems except systems that based persulfate and peroxymonosulfate as an oxidant | 1,4-Benzoquinone | 26 | Was detected after treatment of ATC by different AOP systems | |
| Formic acid | 10 | Detected in all AOP systems except systems that based irradiation as a catalyst | 4-Aminophenol | 16 | Detected in all AOP systems except systems that based persulfate and peroxymonosulfate as an oxidant | |
| Acetic acid | 9 | Mostly detected after oxidation of ACT by electrooxidation systems | 1,2,4-Trihydroxybenzene | 5 | This by-product was frequently detected after oxidation of ACT by photodegradation systems | |
| Oxamic acid | 7 | Detected in all AOP systems except systems that based persulfate and peroxymonosulfate as an oxidant | 4-Methylbenzene-1,2-diol | 2 | Only observed after ACT treatment by systems that based persulfate and peroxymonosulfate as an oxidant | |
| Maleic acid | 5 | Only observed after ACT treatment by systems that photodegradation systems | Benzoic acid | 2 | Benzoic acid frequently detected after electrooxidation of ACT | |
| Malonic acid | 2 | Mostly detected after oxidation of ACT by electrooxidation systems |
| 2 | Only observed after ACT treatment by systems that based persulfate and peroxymonosulfate as an oxidant | |
| 4-Heptanol | 2 | Mostly detected after oxidation of ACT by electrooxidation systems | ||||
| Butanoic acid | 2 | |||||
| Hydroxyacetone | 2 | |||||
| 2-(Acetylamino)-2-propenoic acid | 2 | Only observed after ACT treatment by systems that based persulfate and peroxymonosulfate as an oxidant |
Prediction values of (LC50) (96 h) fathead minnow and Ames mutagenicity for ACT by-productsa
| Name | Chemical structure | The percentage of the frequent by-products out of 64 studies | Fathead minnow, LC50 (96 h) | Ames mutagenicity | |||||
|---|---|---|---|---|---|---|---|---|---|
| Photo catalytic% | Sulfate radical-AOP% | EO% | Other AOP process% | −log (mol L−1) | Predicted value (mg L−1) | Experimental result | Predicted result | ||
|
| |||||||||
| Benzaldehyde |
|
|
| 8% | 8% | 2.98 | 6.82 |
| Mutagenicity negative |
|
| |||||||||
| Hydroquinone |
| 66% | 67% | 62% | 58% | 3.81 | 17.16 | Mutagenicity negative | Mutagenicity negative |
|
|
|
| 17% |
|
| 3.52 | 45.86 |
| Mutagenicity negative |
| 4-Methylbenzene-1,2-diol |
|
| 17% |
|
| 3.65 | 27.57 | Mutagenicity negative | Mutagenicity negative |
| Benzoquinone |
| 37% | 33% | 62% | 33% | 3.49 | 35.11 | Mutagenicity negative | Mutagenicity negative |
| 4-Aminophenol |
| 30% | 42% | 8% | 25% | 3.30 | 54.55 | Mutagenicity negative | Mutagenicity negative |
| Benzoic acid |
| 11% |
| 15% | 8% | 3.21 | 75.43 | Mutagenicity negative | Mutagenicity negative |
| 1,2,4-Trihydroxybenzene |
| 18% | 8% | 8% |
| 3.01 | 24.64 | Mutagenicity negative | Mutagenicity negative |
| 4-Nitrophenol |
| 7% | 25% |
|
| 1.93 | 19.02 | Mutagenicity negative | Mutagenicity negative |
| 4-Aminobenzene-1,2-diol |
|
| 16% |
|
| 3.86 | 43.18 | Mutagenicity negative | Mutagenicity negative |
|
| |||||||||
| Hydroxy-acetic acid |
| 7% |
| 8% | 17% | 1.60 | 1904.50 | Mutagenicity negative | Mutagenicity negative |
| Malonic acid |
| 15% | 8% | 15% | 8% | 2.17 | 704.59 | Mutagenicity negative | Mutagenicity positive |
| Succinic acid |
|
|
|
| 8% | 2.51 | 367.61 |
| Mutagenicity negative |
| Malic acid |
| 11% |
| 8% | 8% | 2.40 | 529.53 |
| Mutagenicity negative |
| Acetamide |
| 26% | 8% | 31% | 33% | 1.97 | 637.40 | Mutagenicity negative | Mutagenicity negative |
| Tartronic acid |
| 4% |
|
| 8% | 2.27 | 644.64 |
| Mutagenicity negative |
| Maleic acid |
| 19% |
| 8% | 17% | 2.59 | 298.69 | Mutagenicity negative | Mutagenicity negative |
| Oxalic acid |
| 19% |
| 38% |
| 2.18 | 592.91 | Mutagenicity negative | Mutagenicity negative |
| Oxamic acid |
| 19% |
| 15% | 8% | 2.23 | 520.93 |
| Mutagenicity negative |
| Butyric acid |
| 7% |
|
|
| 2.29 | 448.12 | Mutagenicity negative | Mutagenicity negative |
| Acetic acid |
| 15% |
| 23% | 50% | 2.66 | 132.49 | Mutagenicity negative | Mutagenicity negative |
|
|
| 14% | 8% | 8% |
| 3.71 | 125.65 | Mutagenicity positive | Mutagenicity negative |
| 4-Heptanol |
|
|
| 15% |
|
| 122.16 |
|
|
| Ethylamine |
|
|
| 8% | 8% | 4.19 | 525.21 | Mutagenicity negative | Mutagenicity negative |
| Hydroxyacetone |
|
|
| 15% |
|
| 3589.95 |
|
|
|
|
|
|
| 8% | 8% | 1.31 | 113.70 |
| Mutagenicity positive |
|
| |||||||||
| ACT dimer |
| 11% |
|
| 8% | 3.46 |
|
| Mutagenicity negative |
| 2-(Acetylamino)-2-propenoic acid |
|
| 16% |
|
|
|
|
|
|
| 2-Hydroxy-4-( |
| 7% |
|
|
|
|
|
|
|
| Formic acid |
| 11% | 17% | 15% | 50% |
|
| Mutagenicity negative | Mutagenicity negative |
Data not available.